Optimising Analytical Technologies & Approaches to Characterisation, Standardisation, Quality & Potency to Permit Efficient Release & Commercial Approval of mRNA Medicines

August 28th - 29th, 2024 | Berlin, Germany

2nd mRNA Analytical Development Summit Europe

Empowering Innovation in Highly Precise, Sensitive & Robust mRNA Analytical Development

With continued pressure on drug development timelines paired with a lack of regulatory guidance, the demand for innovative, efficientand high-throughput analytical methods is crucial to ensure the approval and successful commercialisation of safe and effective mRNA therapeutics and vaccines.

As such, the highly anticipated 2nd mRNA Analytical Development Summit Europe 2024 returns to Berlin as the premier gathering for industry professionals to delve into optimised mRNA analytics. Join us to gain critical expertise and hear the latest techniques adopted by Europe's leading biopharma leaders.

Reuniting 60+ industry experts in Analytical Development, Quality Control, Quality Assurance, CMC, and Regulatory, this forum aims to tackle pivotal challenges within mRNA analytical development including biophysical characterisation, dsRNA, and tail sequence analysis. We will also tackle issues related to analytical techniques to meet CQAs and CPIs for efficient and expeditious approval, as well as hurdles related to improved stability and effective delivery systems for large-scale productions to improve tissue-specific delivery.

Across this comprehensive 2-day forum, we foster a collaborative community of like-minded experts from across Europe. Prepare to engage in dynamic discussions, gain invaluable insights, and forge meaningful connections that propel the field of mRNA therapeutics and vaccines forward.

2nd mRNA Analytical Development Summit Europe

At this leading forum, industry experts will navigate through case-study-led presentations & interactive discussions to:

Uncover 1

Uncover Innovative Biophysical Characterisation Strategies, Uncovering Accurate Analysis of mRNA Stability, Structure & Purity to Ensure Safety, Efficacy & Quality of mRNA Therapeutics & Vaccines

Uncover2 (1)

Unveil How to Facilitate Smooth Approval of your mRNA Medicine Through Standardising Analytical Techniques in Alignment with GMP Guidelines & Creating a Reference Document to Ensure Rapid Approval & Commercial Readiness


Optimize Quantitative Purity & Potency Assays to Improve Contaminant & Bioreactivity Measurements for More Safe & Effective mRNA Drugs for Patients

Our Expert Speakers: